Kim Jong Un brands South Korea primary foe and rules out unity

[ad_1] Leader rules out any chance of unification and dismantles agencies focused on relations with South. [ad_2] Source link

New Hampshire attorney general accuses DNC of voter suppression over primary fight

[ad_1] The Democratic Party’s infighting over the New Hampshire primary just got litigious.  The New Hampshire attorney general’s office on Monday sent a cease-and-desist order to the Democratic National Committee…

Key to the Continuum: Hospice Providers Eye Primary Care Businesses

[ad_1] As hospice providers build out a larger continuum of health care services, some are taking a close look at the primary care space. The term “upstream” has become a…

Opinion | Nikki Haley’s Civil War Battlefield

[ad_1] Nikki Haley made a mess. Part of the job of running for president is being able to think on your feet and answer weird questions that come out of…

Maine’s top election official rules Trump ineligible for 2024 primary ballot

[ad_1] CAMDEN, Maine — Maine’s top election official ruled Thursday that Donald Trump is constitutionally ineligible to appear on the state’s primary ballot next year, fueling a national effort to…

Donald Trump kicked off Colorado primary ballot and Social Security COLA: Morning Rundown

[ad_1] What’s next after the bombshell ruling to kick Donald Trump off Colorado’s primary ballot. Chuck Todd shares his ideas for next year — political and not. And what to…

Azad Engineering IPO: Sachin Tendulkar, PV Sindhu-Backed Company Keeps Primary Market Abuzz

[ad_1] Updated Dec 20, 2023, 02:01 PM IST Azad Engineering IPO GMP Today: T​According to various websites that track unregulated market activities the Azad Engineering IPO was commanding a GMP…

Michigan appeals court rejects challenges to Trump’s spot on 2024 primary ballot

[ad_1] LANSING, Mich. — The Michigan Court of Appeals said Thursday it won’t stop former President Donald Trump from appearing on the state’s 2024 Republican primary ballot, turning aside challenges…

NeuroSense’s Phase 2b ALS Trial Achieves Primary Safety and Tolerability & Secondary Clinical Efficacy Endpoints

[ad_1] Top-Line Results from 6-month double-blind Phase 2b PARADIGM trial with NeuroSense’s lead drug candidate for ALS, PrimeC, include: PrimeC achieved primary safety and tolerability endpoints with a safety and…

Everest Medicines Announces Acceptance of Nefecon® New Drug Applications for the Treatment of Primary IgA Nephropathy in Adult Patients in South Korea

[ad_1] SHANGHAI, Nov. 29, 2023 /PRNewswire/ — Everest Medicines (HKEX 1952.HK, “Everest”, or the “Company”), a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative medicines and vaccines,…